Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02231879 Comparator | Oct 2014 → Oct 2020 | dysgammaglobulinemia, myeloid hemopathy, neutropenia, viral infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02231879 ↗ |
| Route | Subcutaneous | “Study drugs were both given subcutaneously twice daily for 14 months using unmarked prefilled glass syringes” NCT02231879 ↗ |